Announced Fri, 26 Jun · 12:19 IST
Trading Window Closed for Q1 FY27 Results
Compliance View source PDF
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹194.68
prior close
₹204.41
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-0.2+10.2+15.8+13.4+11.2+9.0+4.8+17.6———
Up moveDown movePending
AI summary
Bafna Pharmaceuticals has closed its trading window from July 1, 2026 until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026. This is a routine compliance requirement under SEBI Insider Trading Regulations. During this period, designated persons and their immediate relatives cannot trade in the company shares.
Likely market impact
Routine compliance filing. Signals that Q1 FY27 results are approaching. No direct impact on shareholders.